$186 Million is the total value of Northpond Ventures, LLC's 5 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q1 2022 |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
TELESIS BIO INC | 8 | Q3 2023 | 37.2% |
CANDEL THERAPEUTICS INC | 8 | Q3 2023 | 6.0% |
VIGIL NEUROSCIENCE INC | 7 | Q3 2023 | 65.8% |
DICE THERAPEUTICS INC | 6 | Q1 2023 | 55.7% |
ISOPLEXIS CORP | 5 | Q4 2022 | 28.3% |
PHENOMEX INC | 2 | Q2 2023 | 4.4% |
View Northpond Ventures, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
SC 13D/A | 2023-06-02 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-01 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-01 |
13F-HR | 2022-05-16 |
View Northpond Ventures, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.